DRAFT MTN Regional Meeting Westin Cape Town Hotel Cape Town, South Africa Sunday, October 27, 2013
|
|
|
- Maximilian Gilbert
- 5 years ago
- Views:
Transcription
1 Sunday, October 27, 2013 Registration (Old Harbour Lobby; 7:00 AM to ) 8:30 AM 9:30 AM 1 1 Lunch (Restaurant Thirty 7) 5:30 PM
2 Monday, October 28, :00 AM Registration (Old Harbour Lobby) 8:30 AM ASPIRE TEAM MEETING (Grand Ballroom) 9:30 AM ASPIRE TEAM MEETING (Grand Ballroom) 1 1 Lunch (Restaurant Thirty 7) ASPIRE TEAM MEETING (Grand Ballroom) ASPIRE TEAM MEETING (Grand Ballroom) ENDS AT 5:30 PM VOICE Publications Meeting (Special Invitation Only) 6:30 PM
3 Tuesday, October 29, :00 AM Registration (Old Harbour Lobby) Plenary Session 1: The Prevention Landscape (Grand Ballroom) Moderators: Roberta Black & Mike Chirenje 8:20 AM 8:40 AM 9:20 AM 9:40 AM Network Update (Sharon Hillier & Ian McGowan) An Update on the Prevention Landscape (Susan Buchbinder) HIV Prevention - The DAIDS Perspective (Carl Dieffenbach) Moving PrEP from Clinical Trials to Implementation (Connie Celum) An Update on HIV Vaccine Research (Glenda Gray) Panel Discussion Plenary Session 2: Adherence (Grand Ballroom) Moderators: Cynthia Grossman & Gita Ramjee 10:50 AM 11:10 AM 11:50 AM 12:10 PM Adherence in PrEP/Microbicides (Ariane van der Straten) Monitoring Adherence with PK (Jared Baeten) Emotional Energy: The ASPIRE Participant Workshops (Patrick Ndase) What Defines "Good" in GPP? (Mitchell Warren) Adherence: The Community Perspective (Teopista Nakyanzi) Panel Discussion 1 Lunch (Restaurant Thirty 7) BREAK OUT SESSIONS 1:45 PM 2:15 PM 2:45 PM 3:45 PM 4:15 PM 4:45 PM 6:00 PM 7:00 PM 9:00 PM LAB PHARMACY CWG MTN-016 Team Meeting & Skills Workshop MTN-016 Team Meeting & Skills Workshop Investigator Dinner (Westin Executive Club, 19th Floor) (by invitation only) SITE MTGS (Marion Island)
4 7:00 AM 8:20 AM 8:40 AM 9:20 AM 9:45 AM DRAFT MTN Regional Meeting Wednesday, October 30, 2013 Registration (Old Harbour Lobby) Plenary Session 3: Tenofovir Gel Update (Grand Ballroom) Moderators: Carl Dieffenbach & Lulu Nair VOICE Update: HSV-2 and Beyond (Jeanne Marrazzo & Mike Chirenje) VOICE C: The Complexity of Compliance (Jonathan Stadler) VOICE D: The Participant Perspective (Zoe Duby) CAPRISA 008 (Leila Mansoor) FACTS 001 (Helen Rees) Panel Discussion Plenary Session 4: Contraception (Grand Ballroom) Moderators: Jeanna Piper & Bonus Makanani 10:50 AM 11:05 AM 11:20 AM 11:35 AM 11:50 PM 12:05 PM South African Contraceptive Guidelines (TBN) The Uganda Experience (Clemensia Nakabiito) Changes in Contraceptive use among Women in Microbicide Trials; the Zimbabwe Experience (Felix Mhlanga) Contraceptive Action Team Update (Katie Bunge) Experiences with Broadening the Contraceptive Mix at the CAPRISA ethekwini Site (Ishana Harkoo) Preventing Pregnancy in an HIV Prevention Trial: Lessons Learned from VOICE (Lulu Nair) Panel Discussions 1 Lunch (Restaurant Thirty 7) LAB PHARMACY CWG BREAK OUT SESSIONS SITE MTGS (Marion Island) 1:45 PM 2:15 PM 2:45 PM ASPIRE Workshop (Grand Ballroom) 6:30 PM 8:30 PM ASPIRE Workshop (Grand Ballroom) Reception for all Registrants (Old Harbour Lobby)
5 Thursday, October 31, 2013 Plenary Session 5: Rings, Scholars and More (Grand Ballroom) Moderators: Lydia Soto-Torres & Felix Mhlanga 8:20 AM 8:40 AM 9:20 AM Ring Acceptability: Lessons from US and Indian Women (Barbara Mensch) The Ring Study Update (Annalene Nel) Global Spread of HIV-1 Drug Resistance: Meeting the Challenge (John Mellors) MTN Scholars Program (Connie Celum) CoreTalk SMS Technology: Communicating with Research Participants to Increase Retention and Adherence (Sarita Naidoo) Moderators: Ian McGowan & Sharon Hillier 10:45 AM Participant-Centered Counseling to Enhance Adherence (Melanie Maclachlan) Challenges of Identifying High Risk Women for Microbicide Studies in Malawi (Yamikani Mbilizi) The Path Ahead (Sharon Hillier & Ian McGowan) MTN Award Ceremony & Closing Remarks 1 Meeting Adjourned (NO LUNCH PROVIDED BY MTN) CLOSED MEETING: ASPIRE OPEN LABEL PROTOCOL (Special Invitation Only) (Da Gama/Diaz) 6:00 PM
6 Friday, November 1, :30 AM CLOSED MEETING: ASPIRE OPEN LABEL PROTOCOL (Special Invitation Only) (Da Gama/Diaz) 9:30 AM CLOSED MEETING: ASPIRE OPEN LABEL PROTOCOL (Special Invitation Only) (Da Gama/Diaz) 1
DRAFT MTN 017 Advocate's Consultation Southern Sun Waterfront Cape Town Cape Town, South Africa Friday, October 7, 2011
DRAFT MTN 017 Advocate's Consultation Southern Sun Waterfront Cape Town Friday, October 7, 2011 1 Lunch/Registration 1:00 PM MTN 017 Advocate's Consultation for Cape Town Site (Boardroom 1 & 2) (Special
8:00 AM 1:30 PM. 2:00 PM 2:30 PM 3:00 PM Break (Old Harbour Lobby) 3:30 PM 3:45 PM 4:00 PM 4:15 PM 4:30 PM 4:45 PM 5:00 PM
8:00 AM DRAFT MTN Regional Meeting Sunday, October 18, 2009 Registration (Old Harbour Lobby; 11:30 AM to ) 9:30 AM 10:30 AM 11:00 AM 11:30 AM 11:45 AM Meet the MTN for New Sites (Pitt Core, FHI, NL, SCHARP)
DRAFT MTN Regional Meeting Westin Cape Town Hotel Cape Town, South Africa Saturday, September 22, 2018
Saturday, September 22, 2018 Registration (Old Harbour Lobby; 7:30 AM to ) 1 1 Sunday, September 23, 2018 Registration (Old Harbour Lobby; 7:30 AM to ) MTN EC (Open to EC members only) Ballroom West) MTN
DRAFT MTN Regional Meeting Westin Cape Town Hotel Cape Town, South Africa Sunday, September 17, 2017
Sunday, September 17, 2017 Registration (Old Harbour Lobby; 7:30 AM to ) East) East) 1 1 East) East) Monday, September 18, 2017 Registration (Old Harbour Lobby; 7:00 AM to ) TEAM MEETING ) TEAM MEETING
Contraception and HIV risk in ASPIRE. Jared Baeten University of Washington MTN Regional Meeting, Cape Town, September 2018
Contraception and HIV risk in ASPIRE Jared Baeten University of Washington MTN Regional Meeting, Cape Town, September 2018 Coming up at R4P Risk of HIV-1 acquisition among South African women using a variety
MTN-020/ASPIRE: Beginning to End and Just the Beginning
MTN-020/ASPIRE: Beginning to End and Just the Beginning Jared Baeten MD PhD & Thesla Palanee-Phillips PhD for the MTN-020/ASPIRE Study Team MTN Annual Meeting, March 2016 MTN-020/ASPIRE Study Team MTN-020/ASPIRE
CONTINUED LESSONS FROM VOICE
CONTINUED LESSONS FROM VOICE Z Mike Chirenje MD FRCOG University of Zimbabwe, Dept. of Obstetrics and Gynaecology, College of Health Science, Harare, Zimbabwe VOICE Study Summary VOICE was a RCT (N=5029)
Understanding (non-) adherence: VOICE and Ancillary Studies
Understanding (non-) adherence: VOICE and Ancillary Studies Ariane van der Straten, PhD, MPH Women s Global Health Imperative RTI International San Francisco, CA, USA AVAC Webinar 28 April 2014 1 Presentation
Adolescent PrEP Delivery: Strategies and Tools to Maximize Adherence Young Women in Africa. Jessica Haberer, MD, MS November 9, 2017
Adolescent PrEP Delivery: Strategies and Tools to Maximize Adherence Young Women in Africa Jessica Haberer, MD, MS November 9, 2017 Disclosures I have no conflicts to declare Grant funding: NIH, Gates
The Big Picture: The current and evolving HIV prevention landscape
The Big Picture: The current and evolving HIV prevention landscape Patrick Ndase, MBChB, M.P.H University of Washington Beyond Phase III: Seeking stakeholder perspectives on next steps with the for HIV
Pregnancy Testing Concerns The Ides of March: Et Tu, Quidel? Edward Livant BS, MPH MTN Laboratory Center
Pregnancy Testing Concerns The Ides of March: Et Tu, Quidel? Edward Livant BS, MPH MTN Laboratory Center Sunday, March 15 th 2015 Any Unusually Colored Rings lately? For women with regular 28 day cycles
Behavioral Research in the Microbicide Trials Network
Behavioral Research in the Microbicide Trials Network HANC Behavioral Sciences Working Group Symposium Miami June 8, 2014 Ariane van der Straten, PhD, MPH Member, MTN Behavioral Research Working Group
MTN 2018 State of the Network
MTN 2018 State of the Network Jared Baeten MD PhD Co-PI, Microbicides Trials Network Vice Chair, Department of Global Health Professor, Departments of Global Health, Medicine, and Epidemiology Director,
Gossip, Rumor and Medical Research: Some Findings from VOICE C. Jonathan Stadler Wits Reproductive Health and HIV Institute Johannesburg South Africa
Gossip, Rumor and Medical Research: Some Findings from VOICE C Jonathan Stadler Wits Reproductive Health and HIV Institute Johannesburg South Africa Does the truth matter? Rumors are more than just wrong
Advances in Topical Protection Against HIV-1 Infection. Ross D. Cranston MB ChB MD FRCP Fundació Lluita contra la SIDA Barcelona
Advances in Topical Protection Against HIV-1 Infection Ross D. Cranston MB ChB MD FRCP Fundació Lluita contra la SIDA Barcelona Summary Microbicide background The concept and potential acceptability Vaginal
The Big Picture: The current and evolving HIV prevention landscape
The Big Picture: The current and evolving HIV prevention landscape Sharon Hillier, Ph.D. University of Pittsburgh Beyond Phase III: Seeking civil society perspectives on next steps with the dapivirine
Update on ARV based PrEP
Update on ARV based PrEP Z Mike Chirenje MD FRCOG University of Zimbabwe, College of Health Sciences, Dept. of Obstetrics and Gynaecology Avondale, Harare, Zimbabwe chirenje@uz-ucsf.co.zw Controlling HIV
Biomedical Prevention Update Thomas C. Quinn, M.D.
Biomedical Prevention Update Thomas C. Quinn, M.D. Associate Director of International Research National Institute of Allergy and Infectious Diseases Director, Johns Hopkins Center for Global Health Global
MTN-020. Jared Baeten, MD PhD Thesla Palanee, PhD On behalf of the ASPIRE team MTN Annual Meeting, Bethesda 21 February 2012
MTN-020 Jared Baeten, MD PhD Thesla Palanee, PhD On behalf of the ASPIRE team MTN Annual Meeting, Bethesda 21 February 2012 MTN-020 / ASPIRE A Multi-Center, Randomized, Double- Blind, Placebo-Controlled
Understanding the Results of VOICE
CONTACT: Lisa Rossi +1-412- 916-3315 (mobile) or +27-(0)73-323-0087 (through 7 March) rossil@upmc.edu About VOICE Understanding the Results of VOICE VOICE Vaginal and Oral Interventions to Control the
Addressing the Gaps Between Products and People at Risk
Addressing the Gaps Between Products and People at Risk Albert Liu, MD, MPH Clinical Research Director, Bridge HIV SF Department of Public Health Assistant Clinical Professor of Medicine, UCSF MTN Annual
What We Will Learn From the REACH Study
What We Will Learn From the REACH Study Lulu Nair (MBChB, MPH) MTN 034/IPM 045 Protocol Chair On behalf of protocol team 19 Sep 2017 MTN Regional Meeting 2017 Cape Town Overview Importance / Value of REACH
MTN-020 and IPM 027 and the MTN-020 DSMB. Jared Baeten, MD PhD Thesla Palanee, PhD ASPIRE Protocol Team Meeting 22 February 2012
MTN-020 and IPM 027 and the MTN-020 DSMB Jared Baeten, MD PhD Thesla Palanee, PhD ASPIRE Protocol Team Meeting 22 February 2012 Developing a range of options for antiretroviral-based HIV prevention Pill
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
Original Article Use of a Vaginal Ring Containing for HIV-1 Prevention in Women J.M. Baeten, T. Palanee Phillips, E.R. Brown, K. Schwartz, L.E. Soto Torres, V. Govender, N.M. Mgodi, F. Matovu Kiweewa,
The Open Label Trial Past and Present
The Open Label Trial Past and Present Jared Baeten, M.D., Ph.D. University of Washington Beyond Phase III: Seeking civil society perspectives on next steps with the dapivirine ring for HIV prevention in
abstract n engl j med 375;22 nejm.org December 1,
The new england journal of medicine established in 1812 December 1, 2016 vol. 375 no. 22 Use of a Vaginal Ring Containing for HIV-1 Prevention in Women J.M. Baeten, T. Palanee Phillips, E.R. Brown, K.
The Open Label Trial Past and Present
The Open Label Trial Past and Present Patrick Ndase, MBChB, M.P.H University of Washington Beyond Phase III: Seeking civil society perspectives on next steps with the dapivirine ring for HIV prevention
Translating the Science to End New HIV Infections in Kenya
Translating the Science to End New HIV Infections in Kenya Perspectives, Practices and Lessons Nairobi, 28-30 May 2017 www.iasociety.org AIDS 2016 Post-Conference Workshop Setting the Stage Overview of
Inspiring HIV Prevention Innovations for Women. IPM Satellite Event Durban, 13 th June 2017 Annalene Nel
Inspiring HIV Prevention Innovations for Women IPM Satellite Event Durban, 13 th June 2017 Annalene Nel HIV Infection: Where We Are Today 30+ years since the US CDC reported the first cases of AIDS 25.5
MTN 034/IPM 045: REACH Rings and PrEP in Young Women
MTN 034/IPM 045: REACH Rings and PrEP in Young Women Lulu Nair CRS Leader: Emavundleni -Cape Town On behalf of MTN 034 protocol team MTN Annual Meeting: 2017 Bethesda North Marriott Hotel and Conference
The Evidence Base for Women
The Evidence Base for Women Dr. Busisiwe Msimanga-Radebe WHO South Africa country office ICASA 2017 Abidjan, Cote d Ivoire Combination prevention to break the cycle of HIV transmission Men
Press conferences may be viewed live at or archived at
PRESS CONFERENCES HIV RESEARCH FOR PREVENTION (HIVR4P 2018) Media Center: Pottsdam/Baden Baden rooms, Madrid Marriott Auditorium Hotel Embargoes on oral abstract studies lift at the conclusion of the study
What Do We Really Mean By Adherence in Vaginal Microbicide Trials?
What Do We Really Mean By Adherence in Vaginal Microbicide Trials? A COMPARATIVE STUDY International Conference on HIV Treatment and Prevention Adherence June 9 th, 2014 Miami, USA Lori Miller, MHS PhD
QUESTIONS AND ANSWERS
CONTACT: Lisa Rossi +1-412-641-8940 +1-412- 916-3315 (mobile) rossil@upmc.edu QUESTIONS AND ANSWERS ASPIRE A Study to Prevent Infection with a Ring for Extended Use The Big Picture 1. What is the aim of
Contextual influences on product preference : Lessons from MTN studies
Contextual influences on product preference : Lessons from MTN studies Ariane van der Straten, PhD, MPH Women s Global Health Imperative RTI International San Francisco, CA, USA NIH: The role of relationships
Overview of ARV-based prevention trials
Overview of ARV-based prevention trials Catherine Hankins BA MD MSc CCFP FRCPC Deputy Director, Science Amsterdam Institute for Global Health and Development; Department of Global Health, Academic Medical
MTN Protocols. Study Short Title Countries Status
MTN Protocols Study Short Title Countries Status MTN-001 Adherence and Pharmacokinetics Study of Oral and Vaginal Preparations of Tenofovir South Africa, Uganda, USA Primary analysis complete; published
FINAL PROGRAM IGNITING CHANGE & INNOVATION: THE IMPACT OF HEALTH EDUCATION 1
FINAL PROGRAM IGNITING CHANGE & INNOVATION: THE IMPACT OF HEALTH EDUCATION 1 SCHEDULE AT-A-GLANCE START END EVENT ROOM TUESDAY, APRIL 3 12:00PM 7:00PM REGISTRATION OPEN The Landing 9:00AM 5:00PM CASE STUDY
Where We Have Been and Where We are Going. Ian McGowan MD PhD FRCP
Where We Have Been and Where We are Going Ian McGowan MD PhD FRCP Directions Where we were Where we are headed Where we are 2005 The size of your dreams must always exceed your current capacity to achieve
Pre-Exposure Topical Microbicides and Oral Prophylaxis Trials:
Pre-Exposure Topical Microbicides and Oral Prophylaxis Trials: Rationale, Designs & Issues Connie Celum, MD, MPH Patrick Ndase, MBChB, MPH May 2007 Regional MTN Meeting Importance of HIV prevention Antiretroviral
International Partnership for Microbicides
International Partnership for Microbicides New Directions in Microbicide Research Accelerating an HIV Prevention Revolution: A Roadmap Zeda F. Rosenberg, ScD, Chief Executive Officer Washington, DC, March
Adherence to HIV Prevention and Treatment
Adherence to HIV Prevention and Treatment Key Populations in Zimbabwe and sub-saharan Africa 26-27 April 2018 Sango Conference Centre, Cresta Lodge Harare, Zimbabwe Hosted by the University of Zimbabwe
Impact of Learning HIV Status on Contraceptive Use in the MIRA Trial
Impact of Learning HIV Status on Contraceptive Use in the MIRA Trial Kelly Blanchard, Kelsey Otis, Alan Bostrom, Ariane van der Straten, Gita Ramjee, Guy de Bruyn, Tsungai Chipato, Elizabeth T Montgomery,
NARST Annual International Conference Schedule at a Glance Wyndham Río Mar Río Grande, Puerto Rico
NARST Annual International Conference Schedule at a Glance - 2013 Wyndham Río Mar Río Grande, Puerto Rico Event Friday, April 5 7:30 AM 5:00 PM NARST Executive Board Meeting #1 Caribbean Salon 3 2:00 PM
5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition
5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition SIXTH DRAFT OF THE PROGRAM AUGUST 28, 2014 Wednesday, October 5, 2016 08:00-16:30 Post Graduate course (To be developed by the
Author Manuscript AIDS Behav. Author manuscript; available in PMC 2015 May 01.
NIH Public Access Author Manuscript Published in final edited form as: AIDS Behav. 2014 May ; 18(5): 841 848. doi:10.1007/s10461-014-0752-9. Impact of an Adherence Intervention on the Effectiveness of
Hormonal Contraceptives and HIV Risk: HPTN 035
Hormonal Contraceptives and HIV Risk: HPTN 035 Z. Mike Chirenje MD FRCOG UZ-UCSF Collaborative Research Program Harare, Zimbabwe chirenje@uz-ucsf.co.zw Washington DC 20 Feb 2012 Outline of Presentation
ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF
ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF PrEP MTN Regional Meeting Cape Town 20 September 2017 Dhevium Govender South African Medical Research Council HIV Prevention Research Unit Quality/Regulatory
8/25/2016. Making Preexposure Prophylaxis Available in the Clinic: Considerations and Pathways Forward
WORKSHOP SESSION: MAKING PREEXPOSURE PROPHYLAXIS AVAILABLE IN THE CLINIC: CONSIDERATIONS AND PATHWAYS FORWARD PRE-REGISTRATION IS REQUIRED PLEASE SEE THE CPT INFORMATION DESK IF THIS IS NOT YOUR SELECTED
What do you think about? Beyond Phase III: Seeking stakeholder perspectives on next steps with the dapivirine ring for HIV prevention in women
What do you think about? Beyond Phase III: Seeking stakeholder perspectives on next steps with the dapivirine ring for HIV prevention in women 6 August 2014, Lilongwe Question #1 HIV testing and safety
Conference Program. (Published: August 9, 2017) Hosted by:
Conference Program (Published: August 9, 2017) Hosted by: Friday, September 15 09:00-13:00 Registration Delegates and Speakers Disease- & Region-specific Discussions 12:00 13:00 Lunch 13:00-13:45 Conference
Doing studies of ARV based
Doing studies of ARV based microbicides what s s different, what s s the same? Gonasagrie Nair, MBChB, DTM&H, MPH CAPRISA ethekwini Site Project Director & IoR VOICE Trial OVERVIEW Brief historical overview
Pre-exposure prophylaxis : Systemic and topical. Linda-Gail Bekker The Desmond Tutu HIV Centre UCT SA HIV ClniciansSociety Conference 2012
New biomedical technologies. Pre-exposure prophylaxis : Systemic and topical. Linda-Gail Bekker The Desmond Tutu HIV Centre UCT SA HIV ClniciansSociety Conference 2012 And the last parachute goes to..
EXPERIENCES WITH BROADENING THE CONTRACEPTIVE MIX AT THE CAPRISA ETHEKWINI CRS
EXPERIENCES WITH BROADENING THE CONTRACEPTIVE MIX AT THE CAPRISA ETHEKWINI CRS MTN REGIONAL MEETING October 2013 Ishana Harkoo Overview Background IUCD Implementation Plan (i) Participant and Community
FRIDAY, April 21 LGBT HEALTH WORKFORCE CONFERENCE (Belfer Research Building, 413 East 69 th Street, 3 rd floor Conference Room)
FRIDAY, April 21 LGBT HEALTH WORKFORCE CONFERENCE (Belfer Research Building, 413 East 69 th Street, 3 rd floor Conference Room) 7:30AM-8:30AM 8:30AM-8:55AM 9:00AM- 10:00AM Registration & Breakfast Opening
October 25, 2016 Tuesday. 11:30am-12:45pm Rethinking Toast Leadership Luncheon
The Rotary Institute 2016 Theme Rotary at the Cross Roads Salt Lake Marriott Downtown at City Creek 75 South West Temple, Salt Lake City, UT October 25 th 30 th, 2016 Program Overview Abridged September
ASPIRE Overview Where we are today
ASPIRE Overview Where we are today Flavia Matovu Kiweewa, MBChB, Msc. Makerere University-Johns Hopkins University (MU-JHU) Research Collaboration Beyond Phase III: Seeking civil society perspectives on
PRECONFERENCE SCHEDULE
PRECONFERENCE SCHEDULE PRECONFERENCE A Adolescent Health with Emphasis on Sexual and Reproductive Health Overview: The Centers for Disease Control and Prevention (CDC) indicates that 41% of young people
Where are we going after effectiveness studies?
Where are we going after effectiveness studies? Nyaradzo M. Mgodi (MBChB, MMed) UZ-UCSF Collaborative Research Program Harare, Zimbabwe MTN Annual Meeting 28 March 2011, Arlington, VA Introduction 30 years
Novel HIV Prevention Methods for Women
Novel HIV Prevention Methods for Women State of the art injectables, rings, and antibody-mediated prevention Nyaradzo M Mgodi (MBChB, MMed) Principal Investigator University of Zimbabwe- College of Health
versus CD4. PoC - Messaging - Specificity and - Ethics sensitivity of HIV - Feedback from diagnostic tests demonstration projects
PRE-CONFERENCE WORKSHOPS WEDNESDAY, 24 OCTOBER 2018 10h00 14h00 Pre-Conference Workshop Pre-Conference Workshop Pre-Conference Workshop Pre-Conference Workshop ITREMA trial feedback PrEP for the private
Mucosal Assays in Oral and Long Acting (LA) Antiretroviral PrEP Trials. Ian McGowan MD PhD FRCP University of Pittsburgh Pittsburgh, PA USA
Mucosal Assays in Oral and Long Acting (LA) Antiretroviral PrEP Trials Ian McGowan MD PhD FRCP University of Pittsburgh Pittsburgh, PA USA Overview A brief history of oral/la PrEP research Integration
abstract n engl j med 372;6 nejm.org February 5,
The new england journal of medicine established in 1812 February 5, 2015 vol. 372 no. 6 Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women Jeanne M. Marrazzo, M.D., Gita Ramjee,
Session 1B - Auditorium Adult cases - Adherence - Mental health - STIs - Opportunistic Infections - TB - Drug Interactions Panel discussion
CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding - Previously on PrEP, now
Welcome and State of the Network. Cape Town, South Africa 27 th September 2016
Welcome and State of the Network Cape Town, South Africa 27 th September 2016 The HIV/AIDS Epidemic in 2016 17 million people were accessing antiretroviral therapy 36.7 million people globally were living
PRE-CONFERENCE ACTIVITIES TUESDAY 4 TH - WEDNESDAY 5 TH SEPTEMBER 2018
PRE-CONFERENCE ACTIVITIES TUESDAY 4 TH - WEDNESDAY 5 TH SEPTEMBER 2018 TRANSPOSE MEETING PH.D. MASTER CLASSES 1 2 TRANSPOSE members are invited to attend the pre-conference TRANSPOSE meeting September
An Update on the HIV Prevention Landscape: The Role of Combination Prevention
1 An Update on the HIV Prevention Landscape: The Role of Combination Prevention Susan Buchbinder, MD Bridge HIV, SFDPH; UCSF MTN Regional Meeting October 29, 2013 2 Overview 1. Why combination prevention?
Saturday 8/26/2017 7:00am - 7:00pm Closed 11:00am - 9:00pm Closed Closed
Fall 2017 Opening Weekend Friday 8/25/2017 7:00am - 7:00pm Closed 8:30am - 2:00pm Closed Closed Saturday 8/26/2017 7:00am - 7:00pm Closed 11:00am - 9:00pm Closed Closed Sunday 8/27/2017 7:30 am - 2:00
Participant Arrivals. 13:00-15:20 Coffee / Tea / ML
Program Day 1 Sunday 7 December, 2014 Participant Arrivals 13:00-15:20 Coffee / Tea / ML 15:30 Welcome / PH Clare Shine Vice President & Chief Program Officer Salzburg Global Seminar Albert G. Mulley Jr
Positive Psychology Summer Institute 2005 Schedule Updated June 21, 2005
Positive Psychology Summer Institute 2005 Schedule Updated June 21, 2005 All Summer Institute activities will be at the Inn at Penn, in the St. Marks Ballroom. Following is information on the catered meals
Integration of Behavioral Science in the MTN Where We've Been and Where We're Going. Pamina M. Gorbach MTN Behavioral Research Working Group
Integration of Behavioral Science in the MTN Where We've Been and Where We're Going Pamina M. Gorbach MTN Behavioral Research Working Group Outline BRWG overview Data collection technologies Challenges
DIOXIN SYMPOSIUM MEETING PLANNING
DIOXIN SYMPOSIUM MEETING PLANNING History & General Information A listing of future and past Dioxin Symposia can be found on the Symposium page. The International Dioxin Symposium has been held annually
For questions or comments, please contact:
The Initiative for Multipurpose Prevention Technologies (IMPT) is a product neutral, global collaboration that advances the development of MPTs to address the interlinked risks of unintended pregnancy
HIV Treatment Evolution. Kimberly Y. Smith MD MPH Vice President and Head, Global Research and Medical Strategy Viiv Healthcare
HIV Treatment Evolution Kimberly Y. Smith MD MPH Vice President and Head, Global Research and Medical Strategy Viiv Healthcare Overview of the Evolution of Antiretroviral Therapy Early Treatment 1987
FEBRUARY 23 26, 2015 The Westin Charlotte Hotel Charlotte, North Carolina SPONSORSHIP PROSPECTUS.
The Westin Charlotte Hotel Charlotte, North Carolina SPONSORSHIP PROSPECTUS www.npic-hmit2015.org SPONSORSHIP OPPORTUNITIES Become a sponsor for the NPIC & HMIT 2015 Conference and support the world s
International Partnership for Microbicides
International Partnership for Microbicides Advancing HIV Prevention Options for Women GNP+ Consultation on NPTs Thomas Mertenskoetter 5. 6. July 2010, Amsterdam Leading Causes of Death in Women (Age 15
A MULTIDISCIPLINARY SOCIETY OF HEALTH BEHAVIOR SCHOLARS AND RESEARCHERS
AMERICAN ACADEMY OF HEALTH BEHAVIOR A MULTIDISCIPLINARY SOCIETY OF HEALTH BEHAVIOR SCHOLARS AND RESEARCHERS Theme: Theory and Applications of Multiple Health Behavior Change March 10-13, 2019 Westin Poinsett
Intensive Course in Transcranial Magnetic Stimulation, October 27-31, 2014
MONDAY, OCTOBER 27, 2014 8:30 AM 9:00 AM Introduction to the TMS Course ; Dylan Edwards, PhD 9:00 AM 10:30 AM TMS: Introduction, Mechanisms of Action, and Equipment, Part 1 10:45 AM 12:00 PM TMS: Introduction,
Programme. "Quality Control Laboratories: How to Inspect" PIC/S Pre- Seminar and Seminar
PIC/S Pre- Seminar and Seminar "Quality Control Laboratories: How to Inspect" Programme Hosted by Taiwan Food and Drug Administration, Ministry of Health and Welfare 11-15 September 2017 Grand Victoria
QUESTIONS AND ANSWERS ABOUT PARTNERS PrEP AND VOICE
CONTACT: Lisa Rossi +1-412-641-8940 +1-412- 916-3315 (mobile) rossil@upmc.edu QUESTIONS AND ANSWERS ABOUT PARTNERS PrEP AND VOICE 1. What is the Partners PrEP study? The Partners PrEP Study is a double-blind,
Use of Pre-exposure Prophylaxis (PrEP) in pregnancy for primary prevention of HIV infection in women
Use of Pre-exposure Prophylaxis (PrEP) in pregnancy for primary prevention of HIV infection in women Catherine Hankins MD PhD FRCPC CM Deputy Director, Science Amsterdam Institute for Global Health and
Combination HIV Prevention Research Carl W. Dieffenbach, Ph.D.
Combination HIV Prevention Research Carl W. Dieffenbach, Ph.D. Director, Division of AIDS, NIAID, NIH October 13, 2011 Multiple strategies needed to assemble a wellrounded prevention toolkit Know the epidemics
Room A Room B Room C. Pre-conference workshop: Barbara. O Dea & Kevin Colp. Howard Selkirk Ballroom
AVLIC 2014 Conference and Workshop Program Monday, July 7, 2014 4:00 5:00 Pre-conference workshop: Barbara Pre-conference workshop: Nigel O Dea & Kevin Colp Howard Selkirk Ballroom Assiniboine Ballroom
2011 IDAA Tucson AZ CONFERENCE AGENDA - Wednesday, August 3rd
2011 IDAA Tucson AZ CONFERENCE AGENDA - Wednesday, August 3rd AA AL-ANON IDAA TEEN TWENTIES All AA Meetings 6:30 AM All CME AZ Ballroom Salon 6 All IDAA All CDE in San All Twenties All 's in Tucson All
HIV PREVENTION. ETHICAL CONSIDERATIONS IN DEVELOPING AN EVIDENCE BASE FOR PrEP IN PREGNANT WOMEN
HIV PREVENTION ETHICAL CONSIDERATIONS IN DEVELOPING AN EVIDENCE BASE FOR PrEP IN PREGNANT WOMEN Kristen Sullivan, PhD, MSW Margaret Little, PhD Anne D. Lyerly, MD HIV & pregnancy Approximately 17.8 million
Transmission Networks & Risk of HIV Infection in Young Women in KwaZulu-Natal, South Africa
Transmission Networks & Risk of HIV Infection in Young Women in KwaZulu-Natal, South Africa FIDSSA, Cape Town, November 2017 Quarraisha Abdool Karim, PhD Associate Scientific Director: CAPRISA Professor
PSG 30th Annual Meeting & PSG 32nd Annual Symposium. Friday, April 5 - Monday, April 8, 2019
PSG 30th Annual Meeting & PSG 32nd Annual Symposium Friday, April 5 - Monday, April 8, 2019 Sheraton Grand at Wild Horse Pass Phoenix, Arizona DRAFT: 2.26.19 Parkinson s Foundation Centers Leadership Conference
2015 APA Division 17 Hospitality Space Schedule Wednesday, August 5, 2015 Raptor Room Capacity=40
Wednesday, August 5, 2015 Northern Lights Ballroom Capacity=54 CCPTP Outgoing EB 5-6:50 pm 4pm - 10pm SCP Executive Board and Dinner Section EB Retreat 7-10 pm Please note: Media First Response Training
Conference Program. (Published: August 18, 2017) Hosted by:
Conference Program (Published: August 18, 2017) Hosted by: Friday, September 15 09:00-13:00 Registration Delegates and Speakers Disease & Region-specific Discussions 12:00 13:00 Lunch 13:00-13:45 Conference
The Promise of HIV Prevention in Pregnancy. Richard H. Beigi, MD., MSc. University of Pittsburgh Pittsburgh, PA USA
The Promise of HIV Prevention in Pregnancy Richard H. Beigi, MD., MSc. University of Pittsburgh Pittsburgh, PA USA Outline Pregnancy/Lactation Brief background Where we were Where we are now Where we are
Antiretroviral Drugs for HIV Seronegative People: It works in trials, what about the real world?
Antiretroviral Drugs for HIV Seronegative People: It works in trials, what about the real world? Lut Van Damme 11 Oct 2012 1 Disclaimer Gilead donated the study product for the FEM-PrEP trial I participated
October 8 9, Johannesburg, South Africa. Follow us on or join the conversation with #RTIGender18.
October 8 9, 2018 Johannesburg, South Africa Follow us on Twitter @RTI_Gender or join the conversation with #RTIGender18. Support efforts to End Gender Inequality around the globe. Ending Gender Inequalities
ARVs for prevention in at-risk populations: Microbicides
ARVs for prevention in at-risk populations: Microbicides Treatment as Prevention in Africa Meeting Botswana, April 30 May 3, 2014 Salim S Abdool Karim Director: CAPRISA Pro Vice-Chancellor (Research):
WEDNESDAY, Jun 12. PRECONFERENCE WORKSHOP All Health Professionals 1:00-3:00pm LOWER LIMB ASSESSMENT
WEDNESDAY, Jun 12 PRECONFERENCE WORKSHOP All Health Professionals 1:00-3:00pm LOWER LIMB ASSESSMENT 2019 International Lymphoedema Framework Conference HEALTH PROFESSIONALS DAY Thursday, June 13, 2019:
Texas Crime Prevention Association 2018 Summer Conf.
Texas Crime Prevention Association 2018 Summer Conf. Schedule Sunday, July 8, 2018 8:00am-12:00pm TCPA Advisory Committee Meeting 10:00am-12:00pm Any Region President Meetings and Other State Officer Meetings
Building Health Security Beyond Ebola July 2015, Cape Town, South Africa Agenda
Building Health Security Beyond Ebola 13 15 July 2015, Cape Town, South Africa Agenda MONDAY, 13 July 2015 08.00 09.00 Meeting registration 09.00 09.50 WELCOME AND OPENING REMARKS Grand Ballroom Chair:
2015 Conference Information
2015 Conference Information Photo courtesy of General Electric Company The Frame 6 Users Group 2015 Conference will be held at The DoubleTree by Hilton Paradise Valley Resort, 5401 North Scottsdale Road,
CHARISMA s Impact on HOPE participants at Wits RHI
CHARISMA s Impact on HOPE participants at Wits RHI MTN Regional Meeting, The Westin Hotel, Cape Town, South Africa 21 September 2017 Thesla Palanee-Phillips, PhD, MSc Wits RHI Outline Background What is
There will also be a letter from the president on what to expect at the conference.
CSGS Executive Committee Meeting Conference of Southern Graduate Schools CGS Planning Meeting, Annapolis Loews Annapolis Hotel 126 West Street Annapolis, MD 21401 Minutes of 5/23/2016 A. McCandless called